Table 3.
Medians and Weibull parameters of cardiac adverse events
| Adverse effects | Cases (n) | Median (day) (25–75%) |
Scale parameter | Shape parameter |
|---|---|---|---|---|
| α (95%CI) | β (95%CI) | |||
| Myocarditis | 46 | 36 (20–74) | 58.82 (41.28–82.71) | 0.89 (0.71–1.10) |
| Immune-mediated myocarditis | 32 | 33 (21–97) | 63.76 (41.56–95.97) | 0.90 (0.68–1.16) |
| Pericardial effusion | 24 | 45 (19–100) | 66.73 (44.46–97.88) | 1.12 (0.79–1.51) |
| Cardiac tamponade | 16 | 71 (36–154) | 118.76 (69.20–197.28) | 1.05 (0.70–1.49) |
| Pericarditis | 11 | 71 (29–296) | 117.35 (48.56–268.95) | 0.81 (0.47–1.27) |
| Pericarditis malignant | 5 | 138 (67–168) | 188.25 (84.57–402.52) | 1.45 (0.66–2.58) |
“Cases” indicate the number of reported cases of cardiac adverse events. 95%CI: 95% confidence interval. Detected cardiac adverse event signals were analysed to determine the time to onset